Christopher S Hourigan (C S Hourigan)

Scopus Author ID Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2013-2024
Publications (10 Years): 38

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

medRxiv : the preprint server for health sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Devdeep Mukherjee, Rialnat A Lawal, Courtney D Fitzhugh, Christopher S Hourigan, Laura W Dillon
TP53 mutation screening for patients at risk of myeloid malignancy. Leukemia (2024)
Devdeep Mukherjee, Rialnat A Lawal, Courtney D Fitzhugh, Christopher S Hourigan, Laura W Dillon
TP53 mutation screening for patients at risk of myeloid malignancy. medRxiv : the preprint server for health sciences (2024)
Niveditha Ravindra, Laura W Dillon, Gege Gui, Matthew Smith, Lukasz P Gondek, Richard J Jones, Adam Corner, Christopher S Hourigan, Alexander J Ambinder
Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide. Bone marrow transplantation (2024)
Devdeep Mukherjee, Rialnat A Lawal, Courtney D Fitzhugh, Christopher S Hourigan, Laura W Dillon
TP53 mutation screening for patients at risk of myeloid malignancy. medRxiv : the preprint server for health sciences (2024)
Devdeep Mukherjee, Rialnat A Lawal, Courtney D Fitzhugh, Christopher S Hourigan, Laura W Dillon
TP53 mutation screening for patients at risk of myeloid malignancy. Leukemia 38 (7) (2024)
Devdeep Mukherjee, Rialnat A Lawal, Courtney D Fitzhugh, Christopher S Hourigan, Laura W Dillon
TP53 mutation screening for patients at risk of myeloid malignancy. Leukemia 38 (7) (2024)
Niveditha Ravindra, Laura W Dillon, Gege Gui, Matthew Smith, Lukasz P Gondek, Richard J Jones, Adam Corner, Christopher S Hourigan, Alexander J Ambinder
Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide. Bone marrow transplantation 59 (3) (2024)
Niveditha Ravindra, Laura W Dillon, Gege Gui, Matthew Smith, Lukasz P Gondek, Richard J Jones, Adam Corner, Christopher S Hourigan, Alexander J Ambinder
Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide. Bone marrow transplantation 59 (3) (2024)
Devdeep Mukherjee, Rialnat A Lawal, Courtney D Fitzhugh, Christopher S Hourigan, Laura W Dillon
TP53 mutation screening for patients at risk of myeloid malignancy. Leukemia 38 (7) (2024)
Devdeep Mukherjee, Rialnat A Lawal, Courtney D Fitzhugh, Christopher S Hourigan, Laura W Dillon
TP53 mutation screening for patients at risk of myeloid malignancy. Leukemia (2024)
Devdeep Mukherjee, Rialnat A Lawal, Courtney D Fitzhugh, Christopher S Hourigan, Laura W Dillon
TP53 mutation screening for patients at risk of myeloid malignancy. medRxiv : the preprint server for health sciences (2024)
Christopher S Hourigan
How complete must an AML remission be? Blood 144 (2) (2024)
Niveditha Ravindra, Laura W Dillon, Gege Gui, Matthew Smith, Lukasz P Gondek, Richard J Jones, Adam Corner, Christopher S Hourigan, Alexander J Ambinder
Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide. Bone marrow transplantation (2024)
Devdeep Mukherjee, Rialnat A Lawal, Courtney D Fitzhugh, Christopher S Hourigan, Laura W Dillon
TP53 mutation screening for patients at risk of myeloid malignancy. medRxiv : the preprint server for health sciences (2024)
Gege Gui, Laura W Dillon, Niveditha Ravindra, Pranay S Hegde, Georgia Andrew, Devdeep Mukherjee, Zoë Wong, Jeffery Auletta, Firas El Chaer, Evan Chen, Yi-Bin Chen, Adam Corner, Steven M Devine, Sunil Iyer, Antonio Martin Jimenez Jimenez, Marcos J G De Lima, Mark R Litzow, Partow Kebriaei, Stephen R Spellman, Scott L Zeger, Kristin M Page, Christopher S Hourigan
Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid Leukemia. medRxiv : the preprint server for health sciences (2023)
Michael Boyiadzis, Mei-Jie Zhang, Karen Chen, Hisham Abdel-Azim, Muhammad Bilal Abid, Mahmoud Aljurf, Ulrike Bacher, Talha Badar, Sherif M Badawy, Minoo Battiwalla, Nelli Bejanyan, Vijaya Raj Bhatt, Valerie I Brown, Paul Castillo, Jan Cerny, Edward A Copelan, Charles F Craddock, Bhagirathbhai R Dholaria, Miguel Angel Diaz Perez, Christen L Ebens, Robert Peter Gale, Siddhartha Ganguly, Lohith Gowda, Michael R Grunwald, Shahrukh Hashmi, Gerhard Carl Hildebrandt, Madiha Iqbal, Omer Jamy, Mohamed A Kharfan-Dabaja, Nandita Khera, Hillard M Lazarus, Richard J Lin, Dipenkumar Modi, Sunita Nathan, Taiga Nishihori, Sagar S Patel, Attaphol Pawarode, Wael Saber, Akshay Sharma, Melham M Solh, John L Wagner, Trent P Wang, Kirsten M Williams, Lena E Winestone, Baldeep Wirk, Amer Zeidan, Christopher S Hourigan, Mark R Litzow, Partow Kebriaei, Marcos de Lima, Kristin Page, Daniel J Weisdorf
Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients. Leukemia (2023)
Michael Boyiadzis, Mei-Jie Zhang, Karen Chen, Hisham Abdel-Azim, Muhammad Bilal Abid, Mahmoud Aljurf, Ulrike Bacher, Talha Badar, Sherif M Badawy, Minoo Battiwalla, Nelli Bejanyan, Vijaya Raj Bhatt, Valerie I Brown, Paul Castillo, Jan Cerny, Edward A Copelan, Charles F Craddock, Bhagirathbhai R Dholaria, Miguel Angel Diaz Perez, Christen L Ebens, Robert Peter Gale, Siddhartha Ganguly, Lohith Gowda, Michael R Grunwald, Shahrukh Hashmi, Gerhard Carl Hildebrandt, Madiha Iqbal, Omer Jamy, Mohamed A Kharfan-Dabaja, Nandita Khera, Hillard M Lazarus, Richard J Lin, Dipenkumar Modi, Sunita Nathan, Taiga Nishihori, Sagar S Patel, Attaphol Pawarode, Wael Saber, Akshay Sharma, Melham M Solh, John L Wagner, Trent P Wang, Kirsten M Williams, Lena E Winestone, Baldeep Wirk, Amer Zeidan, Christopher S Hourigan, Mark R Litzow, Partow Kebriaei, Marcos de Lima, Kristin Page, Daniel J Weisdorf
Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients. Leukemia (2023)
Firas El Chaer, Christopher S Hourigan, Amer M Zeidan
How I Treat AML in 2023 Incorporating the Updated Classifications and Guidelines. Blood (2023)
Jurjen Versluis, Wael Saber, Harrison K Tsai, Christopher J Gibson, Laura W Dillon, Asmita Mishra, Joseph P McGuirk, Richard T Maziarz, Peter Westervelt, Pranay S Hegde, Devdeep Mukherjee, Michael J Martens, Brent R Logan, Mary M Horowitz, Christopher S Hourigan, Ryotaro Nakamura, Corey S Cutler, R Coleman Lindsley, null null
Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Laura W Dillon, Jake Higgins, Hassan Nasif, Megan Othus, Lan Beppu, Thomas H Smith, Elizabeth Schmidt, Charles C Valentine, Jesse J Salk, Brent L Wood, Harry P Erba, Jerald P Radich, Christopher S Hourigan
Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia. medRxiv : the preprint server for health sciences (2023)
Hemant S Murthy, Mei-Jie Zhang, Karen Chen, Sairah A Ahmed, Uday Deotare, Siddhartha Ganguly, Ankit Kansagra, Fotios V Michelis, Taiga Nishihori, Mirinal S Patnaik, Muhammad Bilal Abid, Mahmoud Aljurf, Yasuyuki Arai, Ulrike Bacher, Talha Badar, Sherif M Badawy, Karen Ballen, Minoo Battiwalla, Amer Beitinjaneh, Nelli Bejanyan, Vijaya Raj Bhatt, Valerie Inez Brown, Rodrigo Martino, Jean-Yves Cahn, Paul Castillo, Jan Cerny, Saurabh Chhabra, Edward A Copelan, Andrew Daly, Bhagirathbhai R Dholaria, Miguel Angel Diaz Perez, César O Freytes, Michael R Grunwald, Shahrukh K. Hashmi, Gerhard C Hildebrandt, Omer H Jamy, Jacinth Joseph, Christopher G Kanakry, Nandita Khera, Maxwell M Krem, Yachiyo Kuwatsuka, Hillard M Lazarus, Lazaros J Lekakis, Hongtao Liu, Dipenkumar Modi, Pashna Munshi, Alberto Mussetti, Neil Palmisiano, Sagar S Patel, David A Rizzieri, Sachiko Seo, Mithun Vinod Shah, Akshay Sharma, Melhem M Solh, Scott R Solomon, Matthew L Ulrickson, Celalettin Ustun, Marjolein W M van der Poel, Leo F Verdonck, John L Wagner, Trent P Wang, Baldeep Wirk, Amer M Zeidan, Mark R Litzow, Partow Kebriaei, Christopher S Hourigan, Daniel J Weisdorf, Wael Saber, Mohamed A Kharfan-Dabaja
Allogeneic Hematopoietic Cell Transplantation for Blastic Plasmacytoid Dendritic Cell Neoplasm: a CIBMTR analysis. Blood advances (2023)
Niveditha Ravindra, Laura W Dillon, Gege Gui, Matthew Smith, Lukasz P Gondek, Richard J Jones, Adam Corner, Christopher S Hourigan, Alexander J Ambinder
Persistent IDH mutations are not associated with increased relapse or death in patients with IDH -mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide. medRxiv : the preprint server for health sciences (2023)
Meghali Goswami, Gege Gui, Laura W Dillon, Katherine E Lindblad, Julie Thompson, Janet Valdez, Dong-Yun Kim, Jack Y Ghannam, Karolyn A Oetjen, Christin B Destefano, Dana M Smith, Hanna Tekleab, Yeusheng Li, Pradeep Dagur, Thomas Hughes, Jennifer L Marté, Jaydira Del Rivero, Joanna Klubo-Gwiezdzinksa, James L Gulley, Katherine R Calvo, Catherine Lai, Christopher S Hourigan
Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia. Journal for immunotherapy of cancer 10 (1) (2022)
Rialnat AdeBisi Lawal, Devdeep Mukherjee, Emily M Limerick, Wynona Coles, Matthew M Hsieh, Laura W Dillon, Christopher S Hourigan, Courtney D Fitzhugh
Increased incidence of hematologic malignancies in SCD after HCT in adults with graft failure and mixed chimerism. Blood (2022)
Jack Chovanec, Ilker Tunc, Jason Hughes, Joseph Halstead, Allyson Mateja, Yihui Liu, Michael O'Connell, Jiwon Kim, Young Hwan Park, Qinlu Wang, Quang Trong Le, Mehdi Pirooznia, Neil Trivedi, Yun Bai, Yuzhi Yin, Amy P Hsu, Joshua J McElwee, Sheryce Lassiter, Celeste Nelson, Judy Bandoh, Thomas DiMaggio, Julij Selb, Matija Rijavec, Melody C Carter, Hirsh Komarow, Vito Sabato, Joshua A Steinberg, Kurt M Hafer, Elizabeth Feuille, Christopher S Hourigan, Justin Lack, Paneez Khoury, Irina Maric, Roberta Zanotti, Patrizia Bonadonna, Lawrence B Schwartz, Joshua D Milner, Sarah Camille Glover, Didier Gaston Ebo, Peter Korosec, George Caughey, Erica Brittain, Ben Busby, Dean D Metcalfe, Jonathan J Lyons
Genetically determining individualized clinical reference ranges for the biomarker tryptase can limit unnecessary procedures and unmask myeloid neoplasms. Blood advances (2022)
Michael Boyiadzis, Mei-Jie Zhang, Karen Chen, Hisham Abdel-Azim, Muhammad Bilal Abid, Mahmoud Aljurf, Ulrike Bacher, Talha Badar, Sherif M Badawy, Minoo Battiwalla, Nelli Bejanyan, Vijaya Raj Bhatt, Valerie I Brown, Paul Castillo, Jan Cerny, Edward A Copelan, Charles F Craddock, Bhagirathbhai R Dholaria, Miguel Angel Diaz Perez, Christen L Ebens, Robert Peter Gale, Siddhartha Ganguly, Lohith Gowda, Michael R Grunwald, Shahrukh Hashmi, Gerhard Carl Hildebrandt, Madiha Iqbal, Omer Jamy, Mohamed A Kharfan-Dabaja, Nandita Khera, Hillard M Lazarus, Richard J Lin, Dipenkumar Modi, Sunita Nathan, Taiga Nishihori, Sagar S Patel, Attaphol Pawarode, Akshay Sharma, Melham M Solh, John L Wagner, Trent P Wang, Kirsten M Williams, Lena E Winestone, Baldeep Wirk, Christopher S Hourigan, Mark R Litzow, Partow Kebriaei, Marcos de Lima, Kristin Page, Daniel J Weisdorf
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients. Leukemia (2022)
Amer M Zeidan, Jan Philipp Bewersdorf, Rena Buckstein, Mikkael A Sekeres, David P Steensma, Uwe Platzbecker, Sanam Loghavi, Jacqueline Boultwood, Rafael Bejar, John M Bennett, Uma Borate, Andrew M Brunner, Hetty E Carraway, Jane E Churpek, Naval G Daver, Matteo Della Porta, Amy E DeZern, Fabio Efficace, Pierre Fenaux, Maria E Figueroa, Peter Greenberg, Elizabeth A Griffiths, Stephanie Halene, Robert P Hasserjian, Christopher S Hourigan, Nina Kim, Tae Kon Kim, Rami S Komrokji, Vijay Kutchroo, Alan F List, Richard F Little, Ravindra Majeti, Aziz Nazha, Stephen D Nimer, Olatoyosi Odenike, Eric Padron, Mirinal S Patnaik, Gail J Roboz, David A Sallman, Guillermo F Sanz, Maximilian Stahl, Daniel T Starczynowski, Justin Taylor, Zhuoer Xie, Mina L Xu, Michael R Savona, Andrew H Wei, Omar Abdel-Wahab, Valeria Santini
Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes. Leukemia 36 (12) (2022)
Maximilian Stahl, Omar Abdel-Wahab, Andrew H Wei, Michael R Savona, Mina L Xu, Zhuoer Xie, Justin Taylor, Daniel T Starczynowski, Guillermo F Sanz, David A Sallman, Valeria Santini, Gail J Roboz, Mirinal S Patnaik, Eric Padron, Olatoyosi Odenike, Aziz Nazha, Stephen D Nimer, Ravindra Majeti, Richard F Little, Steven D Gore, Alan F List, Vijay Kuchroo, Rami S Komrokji, Tae Kon Kim, Nina Kim, Christopher S Hourigan, Robert P Hasserjian, Stephanie Halene, Elizabeth A Griffiths, Peter L Greenberg, Maria E Figueroa, Pierre Fenaux, Fabio Efficace, Amy E DeZern, Matteo G Della Porta, Naval G Daver, Jane E Churpek, Hetty E Carraway, Andrew M Brunner, Uma Borate, John M Bennett, Rafael Bejar, Jacqueline Boultwood, Sanam Loghavi, Jan Philipp Bewersdorf, Uwe Platzbecker, David P Steensma, Mikkael A Sekeres, Rena J Buckstein, Amer M Zeidan
An agenda to advance research in MDS: A TOP 10 Priority List from the first international workshop in MDS (iwMDS). Blood advances (2022)
Antonio Jimenez Jimenez, Marcos J deLima, Krishna V Komanduri, Trent P Wang, Mei-Jie Zhang, Karen Chen, Hisham Abdel-Azim, Muhammad Bilal Abid, Mahmoud Aljurf, Hassan Alkhateeb, Amer Assal, Ulrike Bacher, Fréderic Baron, Minoo Battiwalla, Amer Beitinjaneh, Nelli Bejanyan, Vijaya Raj Bhatt, Michael Byrne, Jean-Yves Cahn, Mitchell S Cairo, Paul Castillo, Edward Copelan, Zachariah DeFilipp, Miguel Angel Diaz Perez, Mahmoud Elsawy, Robert Peter Gale, Biju George, Michael Richard Grunwald, Gerhard Carl Hildebrandt, William Joseph Hogan, Christopher G Kanakry, Ankit Kansagra, Mohamed A Kharfan-Dabaja, Nandita Khera, Maxwell M Krem, Aleksander Lazaryan, Joseph E Maakaron, Rodrigo Martino, Joseph P McGuirk, Fotios V Michelis, Giuseppe Milone, Asmita Mishra, Hemant S Murthy, Alberto Mussetti, Sunita Nathan, Taiga Nishihori, Richard F Olsson, Neil Palmisiano, Sagar S Patel, Ayman Saad, Sachiko Seo, Akshay Sharma, Melham M Solh, Leo F Verdonck, Baldeep Wirk, Jean A Yared, Mark R Litzow, Partow Kebriaei, Christopher S Hourigan, Wael Saber, Daniel J Weisdorf
An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis. Bone marrow transplantation 56 (12) (2021)
Kamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, Mei-Jie Zhang, Khalid Bo-Subait, Jonathan Sanchez, Hai-Lin Wang, Mahmoud Aljurf, Amer Assal, Vera Ulrike Bacher, Sherif M Badawy, Nelli Bejanyan, Vijaya Raj Bhatt, Christopher N Bredeson, Michael Byrne, Paul Castillo, Jan Cerny, Saurabh Chhabra, Stefan Octavian Ciurea, Zachariah DeFilipp, Nosha Farhadfar, Shahinaz M Gadalla, Robert Peter Gale, Siddhartha Ganguly, Lohith Gowda, Michael Richard Grunwald, Shahrukh K. Hashmi, Gerhard Carl Hildebrandt, Christopher G Kanakry, Ankit Kansagra, Farhad Khimani, Maxwell M Krem, Hillard M Lazarus, Hongtao Liu, Rodrigo Martino Bofarull, Fotios V Michelis, Sunita Nathan, Taiga Nishihori, Richard F Olsson, Ran Reshef, David A Rizzieri, Jacob M Rowe, Bipin P Savani, Sachiko Seo, Akshay Sharma, Melhem Solh, Celalettin Ustun, Leo F Verdonck, Christopher S Hourigan, Brenda M Sandmaier, Mark R Litzow, Partow Kebriaei, Daniel J Weisdorf, Yanming Zhang, Martin S Tallman, Wael Saber
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood advances (2021)
Michael Heuser, Sylvie D Freeman, Gert J Ossenkoppele, Francesco Buccisano, Christopher S Hourigan, Lok Lam Ngai, Jesse Marc Tettero, Costa Bachas, Constance Baer, Marie Christine Bene, Veit L Bücklein, Anna Czyz, Barbara Denys, Richard Dilon, Michaela Feuring-Buske, Monica L Guzman, Torsten Haferlach, Lina Han, Julia K Herzig, Jeffrey L Jorgensen, Wolfgang Kern, Marina Y Konopleva, Francis Lacombe, Marta Libura, Agata Majchrzak, Luca Maurillo, Yishai Ofran, Jan Philippé, Adriana Plesa, Claude Preudhomme, Farhad Ravandi, Christophe Roumier, Marion Subklewe, Felicitas Thol, Arjan A van de Loosdrecht, Bert A van der Reijden, Adriano Venditti, Agnieszka Świątek, Peter J M Valk, Brent L Wood, Roland Bruno Walter, Christian Thiede, Konstanze Döhner, Gail J Roboz, Jacqueline Cloos
2021 Update Measurable Residual Disease in Acute Myeloid Leukemia: European LeukemiaNet Working Party Consensus Document. Blood (2021)
Matthew J Wieduwilt, Leland Metheny, Mei-Jie Zhang, Hai-Lin Wang, Noel Estrada-Merly, David I Marks, A Samar Al-Homsi, Lori S Muffly, Nelson J Chao, David A Rizzieri, Robert Peter Gale, Shahinaz M Gadalla, Mitchell S Cairo, Alberto Mussetti, Steven D Gore, Vijaya Raj Bhatt, Sagar S Patel, Fotios V Michelis, Yoshihiro Inamoto, Sherif M Badawy, Edward Copelan, Neil Palmisiano, Mohamed A Kharfan-Dabaja, Hillard M Lazarus, Siddhartha Ganguly, Christopher N Bredeson, Miguel Angel Diaz Perez, Ryan Cassaday, Bipin P Savani, Karen Kuhn Ballen, Rodrigo Martino Bofarull, Baldeep Wirk, Vera Ulrike Bacher, Mahmoud Aljurf, Asad Bashey, Hemant S Murthy, Jean A Yared, Ibrahim Aldoss, Nosha Farhadfar, Hongtao Liu, Hisham Abdel-Azim, Edmund K Waller, Melhem Solh, Matthew Seftel, Marjolein W M van der Poel, Michael Richard Grunwald, Jane L Liesveld, Rammurti T Kamble, Joseph P McGuirk, Reinhold Munker, Jean-Yves Cahn, Jong Wook Lee, Cesar O Freytes, Maxwell M Krem, Lena E Winestone, Usama Gergis, Sunita Nathan, Richard F Olsson, Leo F Verdonck, Akshay Sharma, Olle Ringdén, Brian D Friend, Jan Cerny, Hannah K Choe, Saurabh Chhabra, Taiga Nishihori, Sachiko Seo, Biju George, Lee Ann Baxter-Lowe, Gerhard Carl Hildebrandt, Marcos J deLima, Mark R Litzow, Partow Kebriaei, Christopher S Hourigan, Muhammad Bilal Abid, Daniel J Weisdorf, Wael Saber
Haploidentical vs. sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia. Blood advances (2021)
Gege Gui, Laura W Dillon, Christopher S Hourigan
Measurable Residual Disease Before Reduced-Intensity Allogeneic Transplantation in Patients With Myeloid Malignancy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (21) (2021)
Jack Ghannam, Laura W Dillon, Christopher S Hourigan
Next-generation sequencing for measurable residual disease detection in acute myeloid leukaemia. British journal of haematology 188 (1) (2019)
Christopher S Hourigan, Robert Peter Gale, Roland Bruno Walter
Refining AML outcome prediction. Leukemia 33 (2) (2018)
Christopher S Hourigan
Haplo, we have a problem. Blood 130 (10) (2018)
Gerrit J Schuurhuis, Michael Heuser, Sylvie Freeman, Marie Christine Bene, Francesco Buccisano, Jacqueline Cloos, David Grimwade, Torsten Haferlach, Robert K Hills, Christopher S Hourigan, Jeffrey L Jorgensen, Wolfgang Kern, Francis Lacombe, Luca Maurillo, Claude Preudhomme, Bert A van der Reijden, Christian Thiede, Adriano Venditti, Paresh Vyas, Brent L Wood, Roland Bruno Walter, Konstanze Döhner, Gail J Roboz, Gert J Ossenkoppele
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party. Blood 131 (12) (2018)
Katherine E Lindblad, Meghali Goswami, Christopher S Hourigan, Karolyn A Oetjen
Immunological effects of hypomethylating agents. Expert review of hematology 10 (8) (2017)
M Goswami, N Hensel, B D Smith, G T Prince, L Qin, H I Levitsky, S A Strickland, M Jagasia, B N Savani, J W Fraser, H Sadrzadeh, T Rajkhowa, S Ito, N A Jain, M Battiwalla, A T Fathi, M J Levis, A J Barrett, Christopher S Hourigan
Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues. Leukemia 28 (5) (2014)
L Qin, B D Smith, H-L Tsai, N K Yaghi, P H Neela, M Moake, J Fu, Y L Kasamon, G T Prince, M Goswami, G L Rosner, H I Levitsky, Christopher S Hourigan
Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapy. Blood cancer journal 3 (2013)
N A Jain, M Y Chen, S Shanbhag, K Lu, P A Pophali, S Ito, E Koklanaris, Christopher S Hourigan, A J Barrett, M Battiwalla
Contrast enhanced cardiac CT reveals coronary artery disease in 45% of asymptomatic allo-SCT long-term survivors. Bone marrow transplantation 49 (3) (2013)